LJL Biosystems has been awarded US Patent No. 6,806,053, “Cell-signaling assays.”

Inventors listed on the patent are: Richard Sportsman and Lawrence Kauvar.

According to its abstract, the patent describes assays for detecting the presence and activity of cell-signaling components. The assays include luminescence polarization assays for detecting cell-signaling nucleotides, and modulators of receptors and enzymes related to the generation and activity of such nucleotides, the abstract states.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more